Xiaomei Tang
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 4
-
- Pancreatic and Hepatic Oncology Research 8
- Cancer Immunotherapy and Biomarkers 4
-
- RNA modifications and cancer 9
- Circular RNAs in diseases 3
-
- Ferroptosis and cancer prognosis 4
-
- Atrial Fibrillation Management and Outcomes 3
- Journals
- Journal of Advanced Research (2 papers)OncoTargets and Therapy (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaFinlandNetherlands
In The Last Decade
Xiaomei Tang
43 papers receiving 849 citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 330
- Oncology 184
- Molecular Biology 439
- Pulmonary and Respiratory Medicine 149
- Pathology and Forensic Medicine 51
Countries citing papers authored by Xiaomei Tang
This map shows the geographic impact of Xiaomei Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomei Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomei Tang more than expected).
Fields of papers citing papers by Xiaomei Tang
This network shows the impact of papers produced by Xiaomei Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomei Tang. The network helps show where Xiaomei Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaomei Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 10 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 6 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 25 | |
| 10 | 2023 | 12 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 14 | |
| 13 | 2021 | 38 | |
| 14 | 2021 | 0 | |
| 15 | 2021 | 5 | |
| 16 | 2020 | 4 | |
| 17 | PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis | 2019 | 2 |
| 18 | 2019 | 13 | |
| 19 | 2016 | 54 | |
| 20 | 2014 | 41 |
About Xiaomei Tang
Xiaomei Tang is a scholar working on Cancer Research, Oncology and Nephrology, having authored 49 papers that have together received 862 indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Pancreatic and Hepatic Oncology Research (8 papers), Cancer-related molecular mechanisms research (8 papers), Ferroptosis and cancer prognosis (4 papers), MicroRNA in disease regulation (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (330 citations), Oncology (184 citations) and Molecular Biology (439 citations). Xiaomei Tang has collaborated with scholars based in China, Finland and Netherlands. Frequent co-authors include Minmin Shi, Chenlei Wen, Jie Zhang, Baiyong Shen, Da Fu, Yu‐Shui Ma, Jibin Liu, Haimin Lu, Jing Deng and Sun Feng. Their work appears in journals such as Journal of Advanced Research, OncoTargets and Therapy, Oncotarget, Cell Death and Disease and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.